Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Leukemia, Myeloid, Acute 12Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Lymphoma 3Leukemia, Promyelocytic, Acute 3Congenital Abnormalities 3Leukemia, Biphenotypic, Acute 2Neutropenia 1Lymphatic Diseases 1Leukemia, Myeloid 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Dendritic Cell Sarcoma, Interdigitating 1Breast Neoplasms 1

Interventions

Immunotherapy, Adoptive 2flumatinib 1fludarabine 1Thiotepa 1Sensitivity and Specificity 1Imatinib Mesylate 1Idarubicin 1Diagnosis 1Deferasirox 1Decitabine 1Daunorubicin 1Cytarabine 1Cladribine 1Busulfan 1Blood Specimen Collection 1Azacitidine 1Anthracyclines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Myeloid × Daunorubicin × Clear all
NCT00111345 2012-05-23

Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents

University Hospital Muenster

Phase 2/3 Unknown
550 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡